News
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. LONDON (AP) — The ...
Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the ...
Adults with perinatally acquired HIV and those with HIV acquired via other routes had similar rates of AIDS-defining conditions during the transition to adult care.
Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, ...
The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
Costa used pharmaceutical firms to divert HIV and cancer drugs across multiple states, selling patients medicine that was purchased on the streets and repackaged, records show.
Responding to the sharp increase in new diagnoses, the Government of Fiji declared an HIV outbreak in January 2025. The HIV Outbreak Response Plan and the previously announced Counter Narcotics and ...
In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...
European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...
Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black.
Gilead on Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers lenacapavir for use as pre-exposure prophylaxis, or PrEP, to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results